The underlying cause of MDS is heterogeneous but mutations in the splicing factor SF3B1 or TET2, a gene that functions in the control of cytosine hydroxymethylation are detected in about 50% of genetically determined MDS. Here, SLU7 is linked to myelodysplastic syndrome.